# Fairfax Cryobank - Houston – FDA Inspection, Nov 7, 2023

Source: https://www.keypedia.com/records/fda_inspections/fairfax-cryobank-houston/89810596-bfe0-449e-92ef-c07f6a2d8ae7
Source feed: FDA_Inspections

> FDA inspection 1223922 of Fairfax Cryobank - Houston, November 07, 2023. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223922
- Company Name: Fairfax Cryobank - Houston
- Inspection Date: 2023-11-07
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1070687 - 2018-10-23
- [FDA Inspection 947529 - 2015-11-05](https://www.keypedia.com/records/fda_inspections/fairfax-cryobank-houston/454fe96b-10f2-4d29-96f3-343176198776)

## Related Officers

- [Bobbi J. Miller](https://www.keypedia.com/people/bobbi-j-miller/e005d16b-d354-4447-8e58-d540b0710467)

Company: https://www.keypedia.com/companies/fairfax-cryobank-houston/1b5ccae7-d7dc-4116-9024-7242c44d7f8e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d